Company Overview and Equity Transactions (Details) $ in Thousands		1 Months Ended	4 Months Ended	12 Months Ended
	Dec. 17, 2019 USD ($) shares	Dec. 31, 2020 USD ($) Product shares	Dec. 31, 2019 shares	Dec. 31, 2020 USD ($) Product	Dec. 31, 2019 USD ($) shares	Sep. 11, 2019 USD ($)
Company Overview [Abstract]
Number of internally-developed proprietary products | Product		1		1
Equity Transactions [Abstract]
Net proceeds from initial public offering				$ 6,215	$ 39,317
At-the-Market Offering [Member]
Equity Transactions [Abstract]
Number of common shares issued (in shares) | shares		930,993	0
Proceeds from issuance of common stock		$ 6,055
Transcation costs		$ 473
At-the-Market Offering [Member] | Maximum [Member]
Equity Transactions [Abstract]
Aggregate offering price						$ 25,000
Public Offering [Member]
Equity Transactions [Abstract]
Number of common shares issued (in shares) | shares	8,050,000				8,050,000
Transcation costs	$ 540
Net proceeds from initial public offering	37,835				$ 37,295
Underwriting discounts	$ 2,415